The US Food and Drug Administration approved the first-ever rapid-acting insulin for reducing blood sugar levels. It calls ...

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.

Merilog will be provided by prefilled pen in a 3 mL dose or in a multiple-dose 10 mL vial ... commercial insurance. NovoLog and Novo Nordisk’s other rapid-acting insulin follow-on Fiasp are ...

The U.S. Food and Drug Administration has approved Sanofi-Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin ... and a 10-mL multiple-dose vial are included in this ...

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

Merilog 100units/mL is supplied as both a 10mL multi-dose vial as well as a 3mL ... has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart), to improve glycemic ...

The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.

Since March 2020, FDA has regulated insulin and a subset of other biological ... use prefilled pen and a 10 mL multiple-dose vial. Like Novolog, Merilog should be given subcutaneously within ...

(Image Credits: Pixabay) The U.S. Food and Drug Administration (USFDA) on Friday approved Merilog as biosimilar to Novolog ... vial,” USFDA said in a statement. Merilog is the third insulin ...

During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...

Feb. 14, 2025 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin ... multiple-dose vial. Merilog is the third ...